| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.993 | 0.002 | 0.993 | Glycogen synthase kinase-3 inhibitor | |||
| 0.746 | 0.003 | 0.746 | Anesthetic general | 0.239 0.055 CID_61106 0.467 0.01 CID_6408 0.37 0.021 CID_9664 | ||
| 0.412 | 0.006 | 0.412 | Anesthetic local | |||
| 0.454 | 0.059 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.477 0.045 CID_61106 0.472 0.047 CID_6408 0.439 0.069 CID_9664 | CID_61106 | |
| 0.405 | 0.059 | 0.474 | GABA C receptor rho-3 antagonist | 0.474 0.033 CID_61106 0.474 0.033 CID_6408 0.474 0.033 CID_9664 | CID_9664 | |
| 0.289 | 0.017 | 0.371 | Alpha-N-acetylglucosaminidase inhibitor | 0.371 0.01 CID_61106 0.365 0.011 CID_6408 0.365 0.011 CID_9664 | CID_61106 | |
| 0.254 | 0.013 | 0.269 | Ferrochelatase inhibitor | 0.269 0.011 CID_61106 0.264 0.011 CID_6408 0.264 0.011 CID_9664 | CID_61106 | |
| 0.338 | 0.126 | 0.41 | 5 Hydroxytryptamine release inhibitor | 0.41 0.072 CID_61106 0.406 0.074 CID_6408 0.337 0.127 CID_9664 | CID_61106 | |
| 0.268 | 0.065 | 0.321 | 5 Hydroxytryptamine uptake stimulant | 0.314 0.038 CID_61106 0.321 0.035 CID_6408 0.321 0.035 CID_9664 | CID_9664 | |
| 0.255 | 0.063 | 0.292 | Tyrosine 3 hydroxylase inhibitor | 0.291 0.038 CID_61106 0.292 0.037 CID_6408 0.292 0.037 CID_9664 | CID_9664 | |
| 0.29 | 0.102 | 0.323 | Calcium channel activator | 0.323 0.07 CID_61106 0.322 0.071 CID_6408 0.266 0.128 CID_9664 | CID_61106 | |
| 0.205 | 0.019 | 0.271 | GABA C receptor agonist | 0.271 0.011 CID_61106 0.269 0.012 CID_6408 0.269 0.012 CID_9664 | CID_61106 | |
| 0.264 | 0.083 | 0.391 | 5 Hydroxytryptamine release stimulant | 0.35 0.056 CID_61106 0.391 0.048 CID_6408 0.322 0.063 CID_9664 | CID_6408 | |
| 0.228 | 0.051 | 0.241 | Nitric-oxide synthase stimulant | 0.241 0.039 CID_61106 0.24 0.04 CID_6408 0.24 0.04 CID_9664 | CID_61106 | |
| 0.199 | 0.049 | 0.331 | Succinate dehydrogenase inhibitor | 0.23 0.03 CID_61106 0.331 0.007 CID_6408 0.228 0.031 CID_9664 | CID_6408 | |
| 0.164 | 0.018 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.174 0.01 CID_61106 0.174 0.01 CID_6408 0.168 0.015 CID_9664 | CID_6408 | |
| 0.168 | 0.024 | 0.344 | UDP-glucose 4-epimerase inhibitor | 0.181 0.021 CID_61106 0.344 0.008 CID_6408 0.18 0.021 CID_9664 | CID_6408 | |
| 0.2 | 0.062 | 0.221 | 5 Hydroxytryptamine 3E antagonist | 0.215 0.042 CID_61106 0.221 0.035 CID_6408 0.221 0.035 CID_9664 | CID_9664 | |
| 0.155 | 0.022 | 0.191 | Creatine kinase inhibitor | 0.183 0.014 CID_61106 0.191 0.012 CID_6408 0.144 0.027 CID_9664 | CID_6408 | |
| 0.156 | 0.025 | 0.162 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.162 0.023 CID_61106 0.161 0.024 CID_6408 0.161 0.024 CID_9664 | CID_61106 | |
| 0.178 | 0.056 | 0.231 | Arachidonic acid antagonist | 0.193 0.04 CID_61106 0.231 0.011 CID_6408 0.19 0.043 CID_9664 | CID_6408 | |
| 0.14 | 0.031 | 0.158 | Adenylate kinase inhibitor | 0.158 0.024 CID_61106 0.157 0.024 CID_6408 0.147 0.027 CID_9664 | CID_61106 | |
| 0.133 | 0.026 | 0.343 | Triose-phosphate isomerase inhibitor | 0.168 0.016 CID_61106 0.343 0.004 CID_6408 0.167 0.016 CID_9664 | CID_6408 | |
| 0.133 | 0.027 | 0.181 | Electrolyte absorption antagonist | 0.15 0.019 CID_61106 0.181 0.011 CID_6408 0.111 0.044 CID_9664 | CID_6408 | |
| 0.201 | 0.098 | 0.213 | RNA-directed DNA polymerase inhibitor | 0.213 0.082 CID_61106 0.212 0.083 CID_6408 0.202 0.096 CID_9664 | CID_61106 | |
| 0.104 | 0.008 | 0.111 | Exportin-1 inhibitor | 0.111 0.005 CID_61106 0.111 0.005 CID_6408 0.083 0.022 CID_9664 | CID_6408 | |
| 0.135 | 0.039 | 0.17 | GABA C receptor antagonist | 0.163 0.024 CID_61106 0.17 0.021 CID_6408 0.16 0.025 CID_9664 | CID_6408 | |
| 0.122 | 0.027 | 0.148 | NADH dehydrogenase inhibitor | 0.144 0.019 CID_61106 0.148 0.018 CID_6408 0.148 0.018 CID_9664 | CID_9664 | |
| 0.123 | 0.042 | 0.133 | DOPA decarboxylase inhibitor | 0.133 0.032 CID_61106 0.133 0.033 CID_6408 0.133 0.033 CID_9664 | CID_9664 | |
| 0.148 | 0.067 | 0.167 | Mannose-6-phosphate isomerase inhibitor | 0.165 0.052 CID_61106 0.167 0.051 CID_6408 0.139 0.075 CID_9664 | CID_6408 | |
| 0.101 | 0.02 | 0.228 | Carbamoyl phosphate synthetase inhibitor | 0.126 0.014 CID_61106 0.228 0.006 CID_6408 0.125 0.015 CID_9664 | CID_6408 | |
| 0.177 | 0.097 | 0.187 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.187 0.085 CID_61106 0.186 0.085 CID_6408 0.156 0.136 CID_9664 | CID_61106 | |
| 0.152 | 0.077 | 0.251 | Peroxidase inhibitor | 0.228 0.052 CID_61106 0.251 0.047 CID_6408 0.251 0.047 CID_9664 | CID_9664 | |
| 0.103 | 0.031 | 0.117 | Phosphofructokinase-1 inhibitor | 0.117 0.026 CID_61106 0.117 0.026 CID_6408 0.117 0.026 CID_9664 | CID_9664 | |
| 0.141 | 0.077 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | 0.156 0.053 CID_61106 0.156 0.052 CID_6408 | CID_6408 | |
| 0.144 | 0.082 | 0.173 | GABA C receptor rho-2 antagonist | 0.173 0.048 CID_61106 0.173 0.048 CID_6408 0.173 0.048 CID_9664 | CID_9664 | |
| 0.07 | 0.014 | 0.081 | Pregnane X receptor antagonist | 0.081 0.006 CID_61106 0.08 0.006 CID_6408 0.062 0.026 CID_9664 | CID_61106 | |
| 0.129 | 0.075 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.141 0.054 CID_61106 0.142 0.052 CID_6408 | CID_6408 | |
| 0.104 | 0.052 | 0.117 | Glutamate (mGluR7) agonist | 0.117 0.033 CID_61106 0.116 0.034 CID_6408 0.093 0.077 CID_9664 | CID_61106 | |
| 0.064 | 0.016 | 0.074 | Glucose-6-phosphate isomerase inhibitor | 0.074 0.01 CID_61106 0.074 0.01 CID_6408 0.074 0.01 CID_9664 | CID_9664 | |
| 0.089 | 0.041 | 0.106 | Porphobilinogen synthase inhibitor | 0.104 0.034 CID_61106 0.106 0.033 CID_6408 0.106 0.033 CID_9664 | CID_9664 | |
| 0.111 | 0.064 | 0.13 | 5 Hydroxytryptamine 3A agonist | 0.127 0.05 CID_61106 0.13 0.048 CID_6408 0.13 0.048 CID_9664 | CID_9664 | |
| 0.056 | 0.009 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.058 0.009 CID_61106 0.057 0.009 CID_6408 0.053 0.012 CID_9664 | CID_61106 | |
| 0.272 | 0.226 | 0.318 | Caspase 9 stimulant | 0.316 0.176 CID_61106 0.318 0.175 CID_6408 0.28 0.217 CID_9664 | CID_6408 | |
| 0.085 | 0.04 | 0.093 | Glutamate decarboxylase inhibitor | 0.093 0.034 CID_61106 0.091 0.035 CID_6408 0.091 0.035 CID_9664 | CID_61106 | |
| 0.075 | 0.03 | 0.081 | Glutamate (mGluR6) antagonist | 0.081 0.023 CID_61106 0.08 0.024 CID_6408 0.08 0.024 CID_9664 | CID_61106 | |
| 0.066 | 0.021 | 0.084 | Aconitate hydratase inhibitor | 0.084 0.012 CID_61106 0.082 0.013 CID_6408 0.082 0.013 CID_9664 | CID_61106 | |
| 0.065 | 0.022 | 0.073 | Dihydroorotate oxidase inhibitor | 0.073 0.015 CID_61106 0.072 0.015 CID_6408 0.056 0.036 CID_9664 | CID_61106 | |
| 0.148 | 0.105 | 0.31 | 3C-like protease (Human coronavirus) inhibitor | 0.162 0.083 CID_61106 0.31 0.009 CID_6408 | CID_6408 | |
| 0.07 | 0.027 | 0.093 | Acyl-CoA dehydrogenase inhibitor | 0.092 0.018 CID_61106 0.093 0.018 CID_6408 0.093 0.018 CID_9664 | CID_9664 | |
| 0.094 | 0.054 | 0.114 | Glutamate release inhibitor | 0.111 0.029 CID_61106 0.114 0.026 CID_6408 0.102 0.04 CID_9664 | CID_6408 | |
| 0.179 | 0.143 | 0.228 | Superoxide dismutase inhibitor | 0.225 0.093 CID_61106 0.228 0.09 CID_6408 0.213 0.104 CID_9664 | CID_6408 | |
| 0.134 | 0.099 | 0.149 | Hexokinase inhibitor | 0.148 0.081 CID_61106 0.149 0.08 CID_6408 | CID_6408 | |
| 0.135 | 0.101 | 0.15 | Interferon gamma antagonist | 0.15 0.078 CID_61106 0.149 0.079 CID_6408 0.134 0.104 CID_9664 | CID_61106 | |
| 0.098 | 0.064 | 0.124 | GABA C receptor rho-1 antagonist | 0.122 0.038 CID_61106 0.124 0.036 CID_6408 0.124 0.036 CID_9664 | CID_9664 | |
| 0.098 | 0.065 | 0.143 | Anabolic | 0.115 0.045 CID_61106 0.143 0.022 CID_6408 0.109 0.051 CID_9664 | CID_6408 | |
| 0.072 | 0.039 | 0.079 | Glutamate (mGluR7) antagonist | 0.079 0.029 CID_61106 0.077 0.031 CID_6408 0.071 0.04 CID_9664 | CID_61106 | |
| 0.064 | 0.03 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.077 0.022 CID_61106 0.08 0.02 CID_6408 0.08 0.02 CID_9664 | CID_9664 | |
| 0.067 | 0.034 | 0.093 | Biliverdin reductase inhibitor | 0.093 0.021 CID_61106 0.091 0.021 CID_6408 0.091 0.021 CID_9664 | CID_61106 | |
| 0.078 | 0.046 | 0.179 | Glutamate dehydrogenase inhibitor | 0.098 0.031 CID_61106 0.179 0.012 CID_6408 0.098 0.032 CID_9664 | CID_6408 | |
| 0.077 | 0.046 | 0.087 | Vanilloid 4 agonist | 0.087 0.03 CID_61106 0.086 0.031 CID_6408 0.083 0.035 CID_9664 | CID_61106 | |
| 0.114 | 0.084 | 0.201 | Cathepsin H inhibitor | 0.121 0.074 CID_61106 0.201 0.022 CID_6408 0.107 0.094 CID_9664 | CID_6408 | |
| 0.085 | 0.055 | 0.089 | D-Ala-D-Ala ligase inhibitor | 0.089 0.046 CID_61106 0.089 0.047 CID_6408 0.089 0.047 CID_9664 | CID_9664 | |
| 0.039 | 0.011 | 0.046 | Calcium-independent phospholipase A2 inhibitor | 0.046 0.005 CID_61106 0.045 0.005 CID_6408 | CID_61106 | |
| 0.129 | 0.101 | 0.146 | Pregnane X receptor agonist | 0.145 0.063 CID_61106 0.146 0.059 CID_6408 | CID_6408 | |
| 0.055 | 0.027 | 0.057 | Potassium channel (Inward rectifier) activator | 0.055 0.026 CID_61106 0.057 0.024 CID_6408 | CID_6408 | |
| 0.077 | 0.05 | 0.153 | GABA aminotransferase inhibitor | 0.085 0.04 CID_61106 0.153 0.007 CID_6408 0.087 0.039 CID_9664 | CID_6408 | |
| 0.044 | 0.017 | 0.052 | Glutamate (mGluR8) agonist | 0.052 0.01 CID_61106 0.052 0.01 CID_6408 0.047 0.014 CID_9664 | CID_6408 | |
| 0.134 | 0.108 | 0.162 | CF transmembrane conductance regulator agonist | 0.161 0.058 CID_61106 0.162 0.057 CID_6408 0.131 0.116 CID_9664 | CID_6408 | |
| 0.052 | 0.026 | 0.054 | Potassium channel (ATP-sensitive) activator | 0.053 0.025 CID_61106 0.054 0.023 CID_6408 | CID_6408 | |
| 0.06 | 0.035 | 0.09 | Alcohol oxidase inhibitor | 0.089 0.021 CID_61106 0.09 0.021 CID_6408 0.09 0.021 CID_9664 | CID_9664 | |
| 0.042 | 0.018 | 0.044 | Fumarate hydratase inhibitor | 0.044 0.016 CID_61106 0.044 0.016 CID_6408 0.044 0.016 CID_9664 | CID_9664 | |
| 0.05 | 0.027 | 0.059 | Adenylate cyclase 1 inhibitor | 0.059 0.019 CID_61106 0.058 0.019 CID_6408 0.045 0.034 CID_9664 | CID_61106 | |
| 0.156 | 0.134 | 0.243 | Aldehyde oxidase inhibitor | 0.225 0.092 CID_61106 0.243 0.085 CID_6408 0.243 0.085 CID_9664 | CID_9664 | |
| 0.099 | 0.078 | 0.259 | Cystathionine beta-synthase inhibitor | 0.13 0.051 CID_61106 0.259 0.014 CID_6408 0.13 0.051 CID_9664 | CID_6408 | |
| 0.071 | 0.051 | 0.077 | Phospholipase D inhibitor | 0.077 0.04 CID_61106 0.076 0.041 CID_6408 0.075 0.043 CID_9664 | CID_61106 | |
| 0.045 | 0.028 | 0.047 | Histamine H1 receptor agonist | 0.045 0.027 CID_61106 0.047 0.023 CID_6408 0.043 0.031 CID_9664 | CID_6408 | |
| 0.023 | 0.006 | 0.038 | Potassium channel (Inward rectifier) 11 blocker | 0.027 0.004 CID_61106 0.038 0.003 CID_6408 | CID_6408 | |
| 0.07 | 0.053 | 0.138 | Aminopeptidase I inhibitor | 0.086 0.037 CID_61106 0.138 0.015 CID_6408 0.085 0.038 CID_9664 | CID_6408 | |
| 0.175 | 0.161 | 0.338 | DNA synthesis inhibitor | 0.2 0.123 CID_61106 0.338 0.033 CID_6408 0.198 0.126 CID_9664 | CID_6408 | |
| 0.05 | 0.036 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.029 CID_61106 0.055 0.029 CID_6408 | CID_6408 | |
| 0.025 | 0.012 | 0.068 | Glutamate (mGluR1a) agonist | 0.04 0.005 CID_61106 0.068 0.004 CID_6408 0.02 0.019 CID_9664 | CID_6408 | |
| 0.04 | 0.031 | 0.044 | Kainate receptor agonist | 0.044 0.022 CID_61106 0.044 0.023 CID_6408 0.044 0.023 CID_9664 | CID_9664 | |
| 0.079 | 0.07 | 0.089 | Estrogen-related receptor beta agonist | 0.089 0.044 CID_61106 0.088 0.044 CID_6408 0.085 0.053 CID_9664 | CID_61106 | |
| 0.069 | 0.061 | 0.079 | Na+ K+ transporting ATPase inhibitor | 0.077 0.053 CID_61106 0.079 0.052 CID_6408 0.071 0.059 CID_9664 | CID_6408 | |
| 0.061 | 0.053 | 0.064 | Transcription factor RelA inhibitor | 0.064 0.044 CID_61106 0.064 0.042 CID_6408 | CID_6408 | |
| 0.055 | 0.048 | 0.12 | Androgen agonist | 0.068 0.033 CID_61106 0.12 0.01 CID_6408 | CID_6408 | |
| 0.069 | 0.062 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.042 CID_61106 0.089 0.023 CID_6408 0.081 0.036 CID_9664 | CID_6408 | |
| 0.029 | 0.022 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.028 0.023 CID_61106 0.03 0.02 CID_6408 0.027 0.025 CID_9664 | CID_6408 | |
| 0.046 | 0.04 | 0.071 | Dopamine beta hydroxylase inhibitor | 0.048 0.035 CID_61106 0.071 0.008 CID_6408 0.047 0.037 CID_9664 | CID_6408 | |
| 0.056 | 0.05 | 0.072 | Purinergic P2X1 antagonist | 0.072 0.03 CID_61106 0.072 0.03 CID_6408 0.065 0.037 CID_9664 | CID_6408 | |
| 0.04 | 0.035 | 0.051 | Nerve growth factor antagonist | 0.051 0.017 CID_61106 0.05 0.018 CID_6408 0.041 0.033 CID_9664 | CID_61106 | |
| 0.036 | 0.031 | 0.039 | Potassium channel Kv1.1 blocker | 0.039 0.024 CID_61106 0.039 0.025 CID_6408 | CID_6408 | |
| 0.025 | 0.021 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 CID_61106 0.029 0.014 CID_6408 | CID_6408 | |
| 0.027 | 0.023 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.013 CID_61106 0.032 0.014 CID_6408 0.032 0.014 CID_9664 | CID_9664 | |
| 0.05 | 0.047 | 0.069 | Argininosuccinate synthase inhibitor | 0.069 0.031 CID_61106 0.067 0.032 CID_6408 0.067 0.032 CID_9664 | CID_61106 | |
| 0.073 | 0.069 | 0.085 | Glycine receptor antagonist | 0.085 0.049 CID_61106 0.084 0.051 CID_6408 0.084 0.051 CID_9664 | CID_61106 | |
| 0.016 | 0.013 | 0.017 | Telomerase stimulant | 0.017 0.013 CID_61106 0.017 0.012 CID_6408 0.017 0.012 CID_9664 | CID_9664 | |
| 0.049 | 0.046 | 0.054 | Alpha-mannosidase inhibitor | 0.052 0.04 CID_61106 0.054 0.037 CID_6408 0.054 0.037 CID_9664 | CID_9664 | |
| 0.122 | 0.12 | 0.142 | Adenylate cyclase stimulant | 0.142 0.077 CID_61106 0.142 0.077 CID_6408 0.142 0.077 CID_9664 | CID_9664 | |
| 0.036 | 0.034 | 0.041 | Vanilloid 3 antagonist | 0.041 0.02 CID_61106 0.041 0.02 CID_6408 | CID_6408 | |
| 0.036 | 0.034 | 0.046 | Dopamine D5 agonist | 0.041 0.026 CID_61106 0.046 0.02 CID_6408 0.046 0.02 CID_9664 | CID_9664 | |
| 0.062 | 0.06 | 0.068 | Histidine decarboxylase inhibitor | 0.068 0.053 CID_61106 0.068 0.053 CID_6408 0.068 0.053 CID_9664 | CID_9664 | |
| 0.082 | 0.08 | 0.188 | Aminopeptidase B inhibitor | 0.141 0.042 CID_61106 0.188 0.024 CID_6408 0.111 0.058 CID_9664 | CID_6408 | |
| 0.146 | 0.145 | 0.185 | Neurotrophic factor enhancer | 0.183 0.094 CID_61106 0.185 0.093 CID_6408 0.155 0.131 CID_9664 | CID_6408 | |
| 0.06 | 0.059 | 0.069 | Calcium channel P-type blocker | 0.067 0.035 CID_61106 0.069 0.03 CID_6408 | CID_6408 | |
| 0.058 | 0.057 | 0.062 | Aryl hydrocarbon receptor antagonist | 0.059 0.055 CID_61106 0.062 0.051 CID_6408 | CID_6408 | |
| 0.025 | 0.024 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 CID_61106 0.028 0.014 CID_6408 | CID_6408 | |
| 0.039 | 0.038 | 0.05 | Cathepsin F inhibitor | 0.05 0.013 CID_61106 0.049 0.014 CID_6408 | CID_61106 | |
| 0.023 | 0.023 | 0.044 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 CID_61106 0.044 0.011 CID_6408 0.026 0.02 CID_9664 | CID_6408 | |
| 0.105 | 0.106 | 0.184 | Sphingosine 1-phosphate receptor 4 antagonist | 0.118 0.076 CID_61106 0.184 0.013 CID_6408 | CID_6408 | |
| 0.019 | 0.021 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 CID_61106 0.023 0.009 CID_6408 | CID_6408 | |
| 0.078 | 0.081 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.048 CID_61106 0.091 0.05 CID_6408 0.091 0.05 CID_9664 | CID_61106 | |
| 0.109 | 0.112 | 0.144 | Nav1.6 sodium channel blocker | 0.136 0.072 CID_61106 0.144 0.062 CID_6408 | CID_6408 | |
| 0.056 | 0.06 | 0.072 | Acetylcholine M5 receptor agonist | 0.072 0.042 CID_61106 0.071 0.043 CID_6408 | CID_61106 | |
| 0.064 | 0.069 | 0.079 | Glycine receptor agonist | 0.079 0.039 CID_61106 0.078 0.041 CID_6408 0.074 0.047 CID_9664 | CID_61106 | |
| 0.026 | 0.03 | 0.03 | MAP3K8 inhibitor | 0.03 0.019 CID_6408 | CID_6408 | |
| 0.021 | 0.026 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 CID_61106 0.023 0.021 CID_6408 | CID_6408 | |
| 0.026 | 0.031 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.024 CID_61106 0.029 0.026 CID_6408 | CID_6408 | |
| 0.032 | 0.037 | 0.04 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 CID_61106 0.039 0.016 CID_6408 | CID_61106 | |
| 0.013 | 0.018 | 0.017 | Carbonic anhydrase X inhibitor | 0.017 0.011 CID_61106 0.017 0.012 CID_6408 0.017 0.012 CID_9664 | CID_9664 | |
| 0.013 | 0.018 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 CID_61106 0.017 0.012 CID_6408 0.017 0.012 CID_9664 | CID_9664 | |
| 0.035 | 0.041 | 0.044 | Thymidine kinase inhibitor | 0.038 0.033 CID_61106 0.044 0.024 CID_6408 | CID_6408 | |
| 0.018 | 0.025 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.017 CID_61106 0.019 0.018 CID_6408 | CID_61106 | |
| 0.009 | 0.017 | 0.012 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 CID_61106 0.012 0.011 CID_6408 | CID_6408 | |
| 0.016 | 0.024 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 CID_61106 0.017 0.015 CID_6408 0.017 0.015 CID_9664 | CID_9664 | |
| 0.039 | 0.047 | 0.043 | Heme oxygenase inhibitor | 0.043 0.03 CID_6408 | CID_6408 | |
| 0.081 | 0.089 | 0.098 | Lanosterol 14 alpha demethylase inhibitor | 0.095 0.064 CID_61106 0.098 0.058 CID_6408 0.09 0.073 CID_9664 | CID_6408 | |
| 0.033 | 0.041 | 0.052 | Membrane dipeptidase inhibitor | 0.037 0.031 CID_61106 0.052 0.014 CID_6408 | CID_6408 | |
| 0.041 | 0.05 | 0.053 | Ornithine carbamoyltransferase inhibitor | 0.053 0.036 CID_61106 0.053 0.037 CID_6408 0.053 0.037 CID_9664 | CID_9664 | |
| 0.008 | 0.017 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 CID_61106 | CID_61106 | |
| 0.017 | 0.027 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 CID_61106 0.022 0.015 CID_6408 | CID_61106 | |
| 0.075 | 0.085 | 0.091 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 CID_61106 0.091 0.064 CID_6408 0.08 0.077 CID_9664 | CID_6408 | |
| 0.022 | 0.032 | 0.031 | Nicotinic alpha4beta2 receptor agonist | 0.031 0.016 CID_61106 | CID_61106 | |
| 0.02 | 0.031 | 0.03 | Glutamate (mGluR1) agonist | 0.025 0.016 CID_61106 0.03 0.01 CID_6408 | CID_6408 | |
| 0.021 | 0.032 | 0.024 | Vanilloid 2 agonist | 0.024 0.021 CID_61106 0.024 0.02 CID_6408 0.024 0.02 CID_9664 | CID_9664 | |
| 0.033 | 0.044 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.033 CID_6408 | CID_6408 | |
| 0.067 | 0.079 | 0.075 | GABA B receptor agonist | 0.075 0.053 CID_61106 0.075 0.053 CID_6408 0.072 0.062 CID_9664 | CID_6408 | |
| 0.012 | 0.024 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 CID_6408 | CID_6408 | |
| 0.009 | 0.021 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_61106 | CID_61106 | |
| 0.023 | 0.037 | 0.027 | Glucosylceramidase stimulant | 0.027 0.019 CID_61106 0.027 0.02 CID_6408 | CID_6408 | |
| 0.023 | 0.037 | 0.027 | Hedgehog signaling activator | 0.027 0.021 CID_61106 0.027 0.02 CID_6408 0.027 0.02 CID_9664 | CID_9664 | |
| 0.043 | 0.057 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.041 CID_61106 0.051 0.041 CID_6408 0.048 0.047 CID_9664 | CID_6408 | |
| 0.061 | 0.075 | 0.063 | MDM2 inhibitor | 0.063 0.061 CID_61106 | CID_61106 | |
| 0.029 | 0.044 | 0.043 | Alpha 1d adrenoreceptor agonist | 0.035 0.032 CID_61106 0.043 0.022 CID_6408 0.039 0.027 CID_9664 | CID_6408 | |
| 0.083 | 0.098 | 0.096 | Carbonic anhydrase XV inhibitor | 0.094 0.077 CID_61106 0.096 0.073 CID_6408 0.088 0.087 CID_9664 | CID_6408 | |
| 0.041 | 0.058 | 0.059 | Squalene epoxidase inhibitor | 0.046 0.042 CID_6408 0.059 0.021 CID_9664 | CID_9664 | |
| 0.06 | 0.077 | 0.066 | CYP2A6 inhibitor | 0.066 0.065 CID_6408 | CID_6408 | |
| 0.064 | 0.082 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.049 CID_61106 0.074 0.051 CID_6408 | CID_61106 | |
| 0.035 | 0.052 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 CID_61106 | CID_61106 | |
| 0.129 | 0.146 | 0.14 | I kappa B kinase epsilon inhibitor | 0.14 0.131 CID_61106 0.14 0.131 CID_6408 | CID_6408 | |
| 0.052 | 0.072 | 0.071 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.048 CID_61106 0.071 0.045 CID_6408 0.071 0.045 CID_9664 | CID_9664 | |
| 0.02 | 0.041 | 0.041 | Liver X receptor antagonist | 0.039 0.014 CID_61106 0.041 0.013 CID_6408 | CID_6408 | |
| 0.017 | 0.038 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 CID_6408 | CID_6408 | |
| 0.026 | 0.047 | 0.031 | Retinoid X alpha receptor antagonist | 0.031 0.03 CID_61106 | CID_61106 | |
| 0.026 | 0.047 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.027 CID_61106 0.03 0.028 CID_6408 | CID_61106 | |
| 0.09 | 0.111 | 0.151 | Microtubule formation inhibitor | 0.104 0.084 CID_61106 0.151 0.037 CID_6408 | CID_6408 | |
| 0.126 | 0.149 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.113 CID_61106 0.131 0.114 CID_6408 | CID_61106 | |
| 0.012 | 0.036 | 0.019 | Complement factor D inhibitor | 0.019 0.012 CID_61106 | CID_61106 | |
| 0.052 | 0.076 | 0.079 | Catalase inhibitor | 0.079 0.048 CID_61106 0.078 0.049 CID_6408 0.067 0.057 CID_9664 | CID_61106 | |
| 0.015 | 0.04 | 0.025 | Factor XIII inhibitor | 0.025 0.008 CID_9664 | CID_9664 | |
| 0.016 | 0.041 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.013 CID_6408 | CID_6408 | |
| 0.085 | 0.11 | 0.1 | Cholesterol synthesis inhibitor | 0.099 0.088 CID_61106 0.1 0.088 CID_6408 | CID_6408 | |
| 0.019 | 0.048 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.016 CID_6408 | CID_6408 | |
| 0.07 | 0.1 | 0.079 | mTOR complex 2 inhibitor | 0.077 0.076 CID_61106 0.079 0.072 CID_6408 | CID_6408 | |
| 0.027 | 0.058 | 0.036 | Delayed rectifier potassium channel blocker | 0.036 0.029 CID_61106 0.035 0.03 CID_6408 | CID_61106 | |
| 0.125 | 0.156 | 0.172 | ATPase inhibitor | 0.148 0.105 CID_61106 0.172 0.068 CID_6408 | CID_6408 | |
| 0.019 | 0.051 | 0.031 | Acid ceramidase inhibitor | 0.031 0.009 CID_6408 | CID_6408 | |
| 0.029 | 0.06 | 0.041 | Guanylate cyclase inhibitor | 0.041 0.032 CID_61106 0.04 0.033 CID_6408 0.039 0.035 CID_9664 | CID_61106 | |
| 0.016 | 0.05 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 CID_6408 | CID_6408 | |
| 0.069 | 0.103 | 0.179 | Alcohol dehydrogenase inhibitor | 0.179 0.015 CID_6408 | CID_6408 | |
| 0.034 | 0.072 | 0.054 | Aldosterone antagonist | 0.054 0.024 CID_9664 | CID_9664 | |
| 0.046 | 0.085 | 0.06 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.044 CID_61106 0.06 0.042 CID_6408 | CID_6408 | |
| 0.019 | 0.059 | 0.033 | Cholesterol ester transfer protein antagonist | 0.033 0.019 CID_6408 | CID_6408 | |
| 0.088 | 0.129 | 0.111 | Toll-Like receptor 2 antagonist | 0.111 0.088 CID_61106 0.109 0.09 CID_6408 | CID_61106 | |
| 0.047 | 0.088 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 CID_6408 | CID_6408 | |
| 0.163 | 0.204 | 0.27 | Cholesterol antagonist | 0.218 0.15 CID_61106 0.27 0.111 CID_6408 0.184 0.18 CID_9664 | CID_6408 | |
| 0.012 | 0.054 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_6408 | CID_6408 | |
| 0.125 | 0.169 | 0.144 | Phospholipase C inhibitor | 0.143 0.122 CID_61106 0.144 0.119 CID_6408 | CID_6408 | |
| 0.028 | 0.074 | 0.056 | Fructose-1,6-bisphosphatase inhibitor | 0.056 0.019 CID_6408 | CID_6408 | |
| 0.022 | 0.069 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 CID_9664 | CID_9664 | |
| 0.04 | 0.087 | 0.05 | Epithelial sodium channel blocker | 0.05 0.049 CID_61106 | CID_61106 | |
| 0.065 | 0.113 | 0.152 | Prolactin inhibitor | 0.152 0.021 CID_6408 | CID_6408 | |
| 0.032 | 0.081 | 0.059 | Cholesterol esterase inhibitor | 0.059 0.019 CID_61106 | CID_61106 | |
| 0.016 | 0.067 | 0.03 | Liver X receptor alpha antagonist | 0.029 0.02 CID_61106 0.03 0.019 CID_6408 | CID_6408 | |
| 0.069 | 0.123 | 0.079 | CC chemokine 5 receptor agonist | 0.078 0.072 CID_61106 0.079 0.07 CID_6408 | CID_6408 | |
| 0.069 | 0.125 | 0.107 | Potassium channel (Voltage-sensitive) activator | 0.107 0.045 CID_6408 | CID_6408 | |
| 0.023 | 0.08 | 0.057 | Adenosine deaminase inhibitor | 0.057 0.024 CID_6408 | CID_6408 | |
| 0.036 | 0.096 | 0.061 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.036 CID_6408 | CID_6408 | |
| 0.024 | 0.084 | 0.049 | Carbonic anhydrase VB inhibitor | 0.049 0.046 CID_6408 | CID_6408 | |
| 0.059 | 0.119 | 0.13 | Glutathione S-transferase inhibitor | 0.13 0.018 CID_6408 | CID_6408 | |
| 0.02 | 0.083 | 0.039 | Potassium channel KCNQ activator | 0.039 0.023 CID_6408 | CID_6408 | |
| 0.02 | 0.083 | 0.039 | Delayed rectifier potassium channel activator | 0.039 0.023 CID_6408 | CID_6408 | |
| 0.046 | 0.111 | 0.082 | Nicotinic alpha4beta2 receptor antagonist | 0.082 0.048 CID_6408 | CID_6408 | |
| 0.006 | 0.071 | 0.016 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 CID_9664 | CID_9664 | |
| 0.056 | 0.129 | 0.078 | Estrogen receptor alpha antagonist | 0.07 0.067 CID_6408 0.078 0.051 CID_9664 | CID_9664 | |
| 0.042 | 0.117 | 0.115 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.115 0.031 CID_6408 | CID_6408 | |
| 0.025 | 0.102 | 0.038 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.034 CID_6408 | CID_6408 | |
| 0.023 | 0.101 | 0.112 | Liver X receptor agonist | 0.043 0.03 CID_61106 0.112 0.006 CID_6408 | CID_6408 | |
| 0.067 | 0.148 | 0.17 | Amylase inhibitor | 0.17 0.055 CID_6408 | CID_6408 | |
| 0.046 | 0.129 | 0.171 | Androgen antagonist | 0.171 0.018 CID_6408 0.076 0.07 CID_9664 | CID_6408 | |
| 0.019 | 0.103 | 0.051 | Antimetabolite | 0.051 0.031 CID_6408 | CID_6408 | |
| 0.011 | 0.097 | 0.051 | Kainate receptor 2 antagonist | 0.051 0.016 CID_9664 | CID_9664 | |
| 0.02 | 0.106 | 0.07 | CDK5/p25 inhibitor | 0.07 0.011 CID_6408 | CID_6408 | |
| 0.083 | 0.17 | 0.146 | Protein kinase stimulant | 0.146 0.071 CID_6408 | CID_6408 | |
| 0.02 | 0.115 | 0.045 | Thymidylate synthase inhibitor | 0.045 0.035 CID_6408 | CID_6408 | |
| 0.029 | 0.124 | 0.075 | TRPA1 antagonist | 0.064 0.038 CID_61106 0.075 0.029 CID_6408 | CID_6408 | |
| 0.169 | 0.265 | 0.26 | Ca(v)3.3 blocker | 0.26 0.086 CID_61106 0.255 0.094 CID_6408 | CID_61106 | |
| 0.037 | 0.138 | 0.104 | Cathepsin G inhibitor | 0.104 0.032 CID_6408 | CID_6408 | |
| 0.012 | 0.115 | 0.032 | Nicotinic acid receptor agonist | 0.032 0.031 CID_6408 | CID_6408 | |
| 0.061 | 0.167 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.079 CID_6408 | CID_6408 | |
| 0.042 | 0.149 | 0.091 | Ornithine decarboxylase inhibitor | 0.091 0.055 CID_6408 | CID_6408 | |
| 0.011 | 0.121 | 0.041 | Kainate receptor antagonist | 0.041 0.028 CID_9664 | CID_9664 | |
| 0.07 | 0.18 | 0.147 | TRPA1 agonist | 0.147 0.033 CID_6408 | CID_6408 | |
| 0.148 | 0.258 | 0.186 | Insulysin inhibitor | 0.186 0.179 CID_61106 | CID_61106 | |
| 0.067 | 0.184 | 0.096 | Nav1.5 sodium channel blocker | 0.096 0.092 CID_6408 | CID_6408 | |
| 0.112 | 0.229 | 0.164 | Neurotensin receptor agonist | 0.164 0.072 CID_6408 | CID_6408 | |
| 0.032 | 0.158 | 0.062 | Sphingosine 1-phosphate receptor 1 antagonist | 0.062 0.026 CID_6408 | CID_6408 | |
| 0.082 | 0.217 | 0.14 | Thiol protease inhibitor | 0.14 0.08 CID_6408 | CID_6408 | |
| 0.082 | 0.223 | 0.147 | DNA repair enzyme inhibitor | 0.147 0.034 CID_6408 | CID_6408 | |
| 0.052 | 0.207 | 0.183 | Alkylator | 0.183 0.032 CID_6408 | CID_6408 | |
| 0.041 | 0.205 | 0.082 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.042 CID_6408 | CID_6408 | |
| 0.078 | 0.263 | 0.157 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.157 0.134 CID_6408 | CID_6408 | |
| 0.009 | 0.199 | 0.044 | Oleamide hydrolase inhibitor | 0.044 0.033 CID_6408 | CID_6408 | |
| 0.02 | 0.214 | 0.067 | Amidase inhibitor | 0.067 0.053 CID_6408 | CID_6408 | |
| 0.038 | 0.233 | 0.077 | Caspase 7 inhibitor | 0.075 0.073 CID_6408 0.077 0.069 CID_9664 | CID_9664 | |
| 0.042 | 0.274 | 0.116 | Caspase 3 inhibitor | 0.104 0.085 CID_6408 0.116 0.067 CID_9664 | CID_9664 | |
| 0.05 | 0.284 | 0.108 | NADPH oxidase inhibitor | 0.108 0.099 CID_6408 | CID_6408 | |
| 0.04 | 0.298 | 0.104 | Proteasome inhibitor | 0.104 0.082 CID_6408 | CID_6408 | |
| 0.076 | 0.347 | 0.158 | Cyclic AMP phosphodiesterase inhibitor | 0.158 0.138 CID_6408 | CID_6408 | |
| 0.003 | 0.275 | 0.013 | Glucocorticoid agonist | 0.013 0.009 CID_6408 | CID_6408 | |
| 0.085 | 0.357 | 0.205 | Histone acetyltransferase inhibitor | 0.205 0.062 CID_6408 | CID_6408 | |
| 0.096 | 0.39 | 0.261 | Vasodilator, coronary | 0.261 0.124 CID_6408 | CID_6408 | |
| 0.058 | 0.362 | 0.181 | Calpain inhibitor | 0.181 0.133 CID_6408 | CID_6408 | |
| 0.059 | 0.399 | 0.284 | DNA damaging | 0.284 0.064 CID_6408 | CID_6408 | |
| 0.065 | 0.414 | 0.216 | Transcription factor NF kappa B inhibitor | 0.216 0.154 CID_6408 | CID_6408 | |
| 0.059 | 0.412 | 0.246 | Calpain 2 inhibitor | 0.246 0.152 CID_6408 | CID_6408 | |
| 0.032 | 0.495 | 0.176 | ABCA1 expression enhancer | 0.176 0.012 CID_6408 | CID_6408 | |
| 0.04 | 0.558 | 0.191 | Hypoxia-inducible factor 1 alpha inhibitor | 0.191 0.163 CID_6408 | CID_6408 | |
| 0.002 | 0.663 | 0.097 | Estrogen receptor alpha agonist | 0.097 0.009 CID_9664 | CID_9664 | |
| 0.013 | 0.679 | 0.083 | CXC chemokine 1 receptor antagonist | 0.083 0.008 CID_61106 | CID_61106 | |
| 0.002 | 0.811 | 0.614 | Estrogen receptor beta agonist | 0.614 0.002 CID_9664 | CID_9664 | |
| 0.013 | 0.826 | 0.098 | CDK3/cyclin E inhibitor | 0.098 0.092 CID_6408 | CID_6408 | |
| 0.002 | 0.929 | 0.535 | Estrogen agonist | 0.535 0.003 CID_9664 | CID_9664 | |
| 0.014 | 0.942 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 CID_6408 | CID_6408 | |
| 0.008 | 0.943 | 0.127 | Antiviral (Hepatitis D) | 0.127 0.004 CID_9664 | CID_9664 | |
| 0.002 | 0.949 | 0.054 | Elastase 2 inhibitor | 0.054 0.005 CID_61106 | CID_61106 | |
| 0.002 | 0.949 | 0.054 | Elastase 2A inhibitor | 0.054 0.005 CID_61106 | CID_61106 | |
| 0.031 | 0.986 | 0.171 | CC chemokine 6 receptor antagonist | 0.171 0.007 CID_61106 | CID_61106 | |
| 0.004 | 0.971 | 0.076 | Histone deacetylase stimulant | 0.076 0.048 CID_6408 | CID_6408 | |
| 0.004 | 0.971 | 0.076 | Histone deacetylase SIRT1 stimulant | 0.076 0.048 CID_6408 | CID_6408 | |
| 0.006 | 0.974 | 0.206 | Chymotrypsin inhibitor | 0.206 0.008 CID_61106 0.166 0.014 CID_6408 | CID_61106 | |
| 0.002 | 0.982 | 0.079 | Fibroblast growth factor 4 antagonist | 0.079 0.019 CID_9664 | CID_9664 | |
| 0.003 | 0.992 | 0.12 | Estrogen antagonist | 0.12 0.056 CID_9664 | CID_9664 | |
| 0.002 | 0.993 | 0.248 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.248 0.002 CID_9664 | CID_9664 | |
| 0.004 | 0.995 | 0.454 | Interleukin 1b antagonist | 0.454 0.005 CID_9664 | CID_9664 | |
| 0.004 | 0.995 | 0.123 | Thioredoxin reductase inhibitor | 0.123 0.016 CID_6408 | CID_6408 | |
| 0.002 | 0.995 | 0.365 | Cyclin-dependent kinase 5 inhibitor | 0.365 0.006 CID_6408 | CID_6408 | |
| 0.003 | 0.996 | 0.269 | Interleukin 1 antagonist | 0.269 0.015 CID_9664 | CID_9664 | |
| 0.003 | 0.997 | 0.189 | Thioredoxin inhibitor | 0.189 0.009 CID_6408 | CID_6408 | |
| 0.002 | 0.995 | 0.036 | Nicotinic acid receptor 2 agonist | 0.036 0.025 CID_9664 | CID_9664 | |
| 0.002 | 0.996 | 0.494 | Thioredoxin glutathione reductase inhibitor | 0.494 0.03 CID_6408 | CID_6408 | |
| 0.002 | 0.997 | 0.207 | Hypoglycemic | 0.207 0.106 CID_61106 | CID_61106 | |
| 0.002 | 0.997 | 0.09 | Telomerase inhibitor | 0.09 0.038 CID_6408 | CID_6408 | |
| 0.001 | 0.997 | 0.111 | Neuraminidase inhibitor | 0.111 0.012 CID_9664 | CID_9664 | |
| 0.002 | 0.997 | 0.51 | Electron transport complex I inhibitor | 0.51 0.003 CID_9664 | CID_9664 | |
| 0.001 | 0.997 | 0.199 | Topoisomerase II alpha inhibitor | 0.199 0.015 CID_61106 | CID_61106 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |